相似文献
1
Rationale for reading fluconazole MICs at 24 hours rather than 48 hours when testing Candida spp. by the CLSI M27-A2 standard method.
Antimicrob Agents Chemother. 2008 Nov;52(11):4175-7. doi: 10.1128/AAC.00420-08. Epub 2008 Sep 22.
2
3
Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
J Clin Microbiol. 2006 Feb;44(2):324-6. doi: 10.1128/JCM.44.2.324-326.2006.
4
[Disk diffusion method for fluconazole susceptibility testing of Candida spp. isolates].
Rev Argent Microbiol. 2006 Jul-Sep;38(3):155-63.
5
Disk diffusion test and E-test with enriched Mueller-Hinton agar for determining susceptibility of Candida species to voriconazole and fluconazole.
J Microbiol Immunol Infect. 2009 Apr;42(2):148-53.
6
Multicenter comparison of the VITEK 2 yeast susceptibility test with the CLSI broth microdilution reference method for testing fluconazole against Candida spp.
J Clin Microbiol. 2007 Mar;45(3):796-802. doi: 10.1128/JCM.01986-06. Epub 2007 Jan 10.
7
Comparison of visual 24-hour and spectrophotometric 48-hour MICs to CLSI reference microdilution MICs of fluconazole, itraconazole, posaconazole, and voriconazole for Candida spp.: a collaborative study.
J Clin Microbiol. 2005 Sep;43(9):4535-40. doi: 10.1128/JCM.43.9.4535-4540.2005.
8
In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest.
J Antimicrob Chemother. 2007 Apr;59(4):767-71. doi: 10.1093/jac/dkl555. Epub 2007 Feb 9.
9
[In vitro activity of amphotericin B, fluconazole and itraconazole against Candida glabrata strains isolated from clinical samples].
Mikrobiyol Bul. 2007 Apr;41(2):235-44.
10
In vitro susceptibilities to yeasts using the ATB FUNGUS 2 method, compared with Sensititre Yeast One and standard CLSI (NCCLS) M27-A2 methods.
J Antimicrob Chemother. 2007 Sep;60(3):658-61. doi: 10.1093/jac/dkm247. Epub 2007 Jul 10.
引用本文的文献
1
Twenty Years in EUCAST Anti-Fungal Susceptibility Testing: Progress & Remaining Challenges.
Mycopathologia. 2024 Jul 11;189(4):64. doi: 10.1007/s11046-024-00861-2.
2
Systematic truncations of chromosome 4 and their responses to antifungals in Candida albicans.
J Genet Eng Biotechnol. 2021 Jun 21;19(1):92. doi: 10.1186/s43141-021-00197-0.
3
Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies.
Open Forum Infect Dis. 2021 May 16;8(6):ofab250. doi: 10.1093/ofid/ofab250. eCollection 2021 Jun.
4
Identification of Candida Species and Antifungal Susceptibility in Cancer Patients with Oral Lesions in Ahvaz, Southern West of Iran.
Adv Biomed Res. 2020 Sep 30;9:50. doi: 10.4103/abr.abr_214_19. eCollection 2020.
5
Factors influencing susceptibility testing of antifungal drugs: a critical review of document M27-A4 from the Clinical and Laboratory Standards Institute (CLSI).
Braz J Microbiol. 2020 Dec;51(4):1791-1800. doi: 10.1007/s42770-020-00354-6. Epub 2020 Aug 5.
6
Identification of Candida species in patients with oral lesion undergoing chemotherapy along with minimum inhibitory concentration to fluconazole.
Adv Biomed Res. 2016 Aug 30;5:132. doi: 10.4103/2277-9175.187394. eCollection 2016.
7
Propensity Score Analysis of the Role of Initial Antifungal Therapy in the Outcome of Candida glabrata Bloodstream Infections.
Antimicrob Agents Chemother. 2016 May 23;60(6):3291-300. doi: 10.1128/AAC.00195-16. Print 2016 Jun.
8
Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012.
J Clin Microbiol. 2012 Sep;50(9):2846-56. doi: 10.1128/JCM.00937-12. Epub 2012 Jun 27.
9
Validation of 24-hour flucytosine MIC determination by comparison with 48-hour determination by the Clinical and Laboratory Standards Institute M27-A3 broth microdilution reference method.
J Clin Microbiol. 2011 Dec;49(12):4322-5. doi: 10.1128/JCM.05479-11. Epub 2011 Oct 19.
10
Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome.
BMC Infect Dis. 2011 Sep 30;11:261. doi: 10.1186/1471-2334-11-261.
本文引用的文献
1
Correlation of the MIC and dose/MIC ratio of fluconazole to the therapeutic response of patients with mucosal candidiasis and candidemia.
Antimicrob Agents Chemother. 2007 Oct;51(10):3599-604. doi: 10.1128/AAC.00296-07. Epub 2007 Jul 23.
2
High- versus low-dose fluconazole therapy for empiric treatment of suspected invasive candidiasis among high-risk patients in the intensive care unit: a cost-effectiveness analysis.
Curr Med Res Opin. 2007 May;23(5):1057-65. doi: 10.1185/030079907x182130.
3
Statistical analyses of correlation between fluconazole MICs for Candida spp. assessed by standard methods set forth by the European Committee on Antimicrobial Susceptibility Testing (E.Dis. 7.1) and CLSI (M27-A2).
J Clin Microbiol. 2007 Jan;45(1):109-11. doi: 10.1128/JCM.01969-06. Epub 2006 Nov 8.
4
Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study.
Clin Infect Dis. 2006 Jul 1;43(1):25-31. doi: 10.1086/504810. Epub 2006 May 16.
5
Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing.
Clin Microbiol Rev. 2006 Apr;19(2):435-47. doi: 10.1128/CMR.19.2.435-447.2006.
6
A retrospective Evaluation of fluconazole for the treatment of Candida glabrata fungemia.
Clin Ther. 2005 Aug;27(8):1228-37. doi: 10.1016/j.clinthera.2005.08.007.
7
Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality.
Antimicrob Agents Chemother. 2005 Sep;49(9):3640-5. doi: 10.1128/AAC.49.9.3640-3645.2005.
8
Multicenter comparison of the Sensititre YeastOne colorimetric antifungal panel with the NCCLS M27-A2 reference method for testing new antifungal agents against clinical isolates of Candida spp.
J Clin Microbiol. 2004 Feb;42(2):718-21. doi: 10.1128/JCM.42.2.718-721.2004.
9
Correlation between E-test, disk diffusion, and microdilution methods for antifungal susceptibility testing of fluconazole and voriconazole.
Antimicrob Agents Chemother. 2003 May;47(5):1647-51. doi: 10.1128/AAC.47.5.1647-1651.2003.
10
Comparative evaluation of NCCLS M27-A and EUCAST broth microdilution procedures for antifungal susceptibility testing of candida species.
Antimicrob Agents Chemother. 2002 Nov;46(11):3644-7. doi: 10.1128/AAC.46.11.3644-3647.2002.
Zotero 插件